PRPO Precipio

Precipio & ADS Biotec Launch Seven Beta sites for IV-Cell™

Precipio & ADS Biotec Launch Seven Beta sites for IV-Cell™
EN
06/10/2020

Underlying

PRPOPrecipio

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Precipio

 PRESS RELEASE
Free
PRPO PRECIPIO

Precipio Takes Major Steps Toward a Clean Balance Sheet

Precipio Takes Major Steps Toward a Clean Balance Sheet Less than $80,000 of long-term debt, and 10,000 vendor warrants remain outstanding NEW HAVEN, Conn., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company   has made major strides in cleaning up its balance sheet with two major accomplishments: 1. Major obligation repaid A $1.1 million advance from Change Healthcare (“CHC”), the Company’s clearinghouse service for billing claims processing, has been repaid. CHC experienced a cybersecurity incident in 2024 and advanced Precipio and others funds to cover collection...

January 15, 2026 1 EN
 PRESS RELEASE
Free
PRPO PRECIPIO

Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society...

Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting Joint study conducted with Memorial Sloan Kettering Cancer Center demonstrates clear, positive impacts on patient care NEW HAVEN, Conn., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company   will be presenting at ASH the findings of a joint study conducted with scientific collaborators from in New York, evaluating Precipio’s BCR::ABL1 assay. The data from a comprehensive study includes 895 patient samples and demonstrates superior performance of the assay, while showing con...

December 5, 2025 1 EN
 PRESS RELEASE
Free
PRPO PRECIPIO

Precipio Identifies Unauthorized Access to Isolated Storage; No Operat...

Precipio Identifies Unauthorized Access to Isolated Storage; No Operational Impact NEW HAVEN, Conn., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Precipio, Inc. reports that the Company recently identified a single, limited scope unauthorized access to a specific data folder stored within its secure cloud file environment. The incident was limited to its file storage server and did not impact any of Precipio’s operations, diagnostics processes, or customer services, and the company continued to provide its services unhindered. There was no impact to patient care; nor impact to the company’s operatio...

December 4, 2025 1 EN
 PRESS RELEASE
Free
PRPO PRECIPIO

Precipio Announces its Q3-2025 Financial Results

Precipio Announces its Q3-2025 Financial Results Over $450,000 Adjusted EBITDA and $275,000 positive operating cash flow for the quarter NEW HAVEN, Conn., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  , filed its 10-Q report today. The following are the highlights of the Company’s financial performance and outlook for the remainder of 2025. Q3-2025 Financial Results: Revenues. Q3-2025 revenues reached $6.8M, a 30% increase YoY from $5.2M in Q3-2024, and a QoQ increase of 20% from $5.7M in Q2-2025. Pathology Services Division's services revenue increased 20% f...

November 14, 2025 1 EN
 PRESS RELEASE
Free
PRPO PRECIPIO

Precipio Announces Q3-2025 Shareholder Update Call

Precipio Announces Q3-2025 Shareholder Update Call Conference Call to be held on November 17th, 2025 at 5:00 PM EST NEW HAVEN, Conn., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  , will be hosting its Q3-2025 corporate update call on November 17th, 2025 at 5:00 PM ET. The call will include updates on all of the company’s current core businesses. The conference call may be accessed by calling 800.717.1738. All callers should ask for the Precipio conference call. Listeners interested in submitting questions in advance should email their questions to  and manag...

November 4, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch